Head and Neck Cancer Trial, Recruiting NCT06681935 Sponsor: Medical College of Wisconsin Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT06681935
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are able to give their own signed and dated consent to participate.
  • People who are willing to follow all study procedures and remain available for the full duration of the study.
  • People who are 21 years of age or older.
  • People who are already scheduled to have oral cavity reconstruction surgery where ampicillin/sulbactam is planned to be used as the preventive antibiotic.
  • People whose planned surgery involves creating a connection between the mouth and the soft tissues of the neck, which will then be repaired using a tissue flap taken from another part of the body or a nearby area.
  • People who have a history of cancer in the mouth or the back of the throat (oropharyngeal cancer).

Who may not be able to join:

  • People who have an allergy to ampicillin/sulbactam (an antibiotic medication).
  • People who are pregnant.
  • People who are currently incarcerated (in prison).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joseph Zenga, MD, Medical College of Wisconsin

Phone: 866-680-0505

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Medical College of Wisconsin
Registry
ClinicalTrials.gov
Start date
29 April 2025
Est. completion
15 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Source of bacteria leading to a surgical site infection

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov